DK3387156T3 - Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme - Google Patents

Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme Download PDF

Info

Publication number
DK3387156T3
DK3387156T3 DK16820182.0T DK16820182T DK3387156T3 DK 3387156 T3 DK3387156 T3 DK 3387156T3 DK 16820182 T DK16820182 T DK 16820182T DK 3387156 T3 DK3387156 T3 DK 3387156T3
Authority
DK
Denmark
Prior art keywords
obesity
treatment
metabolic diseases
lactobacillus casei
associated metabolic
Prior art date
Application number
DK16820182.0T
Other languages
English (en)
Inventor
Barry Kiely
Eileen Frances Murphy
Selena Healy
Original Assignee
Prec Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec Group Limited filed Critical Prec Group Limited
Application granted granted Critical
Publication of DK3387156T3 publication Critical patent/DK3387156T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK16820182.0T 2015-12-11 2016-12-09 Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme DK3387156T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15199657 2015-12-11
PCT/EP2016/080449 WO2017097984A1 (en) 2015-12-11 2016-12-09 Lactobacillus casei for treating obesity and associated metabolic disorders

Publications (1)

Publication Number Publication Date
DK3387156T3 true DK3387156T3 (da) 2020-08-03

Family

ID=55083278

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16820182.0T DK3387156T3 (da) 2015-12-11 2016-12-09 Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme

Country Status (7)

Country Link
US (2) US20180360092A1 (da)
EP (1) EP3387156B1 (da)
CN (1) CN109312297B (da)
DK (1) DK3387156T3 (da)
ES (1) ES2807915T3 (da)
PL (1) PL3387156T3 (da)
WO (1) WO2017097984A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10741091B2 (en) * 2016-02-05 2020-08-11 ThinkCERCA.com, Inc. Methods and systems for mitigating the effects of intermittent network connectivity in educational settings
TWI739078B (zh) * 2018-04-25 2021-09-11 日商曾根農場股份有限公司 脂肪累積抑制用組成物
KR20220008252A (ko) 2018-10-24 2022-01-20 노보자임스 에이/에스 락토바실러스를 포함하는 대사 건강을 위한 프로바이오틱 보조제
CN109628358B (zh) * 2019-02-20 2021-03-19 无限极（中国）有限公司 一种复合益生菌及其应用
CN113207960B (zh) * 2020-08-31 2023-02-28 内蒙古蒙牛乳业（集团）股份有限公司 改善肥胖的乳双歧杆菌MN-Gup发酵乳及制备方法
CN114145461B (zh) * 2021-11-26 2023-10-31 广州能靓生物技术有限公司 一种缓解非酒精性脂肪肝的益生菌组合物
CN114617265B (zh) * 2022-05-16 2022-08-09 天津创源生物技术有限公司 一种灭活干酪乳杆菌iob-p9后生元粉在降糖方面的应用
CN116590181B (zh) * 2023-04-28 2024-01-12 微康益生菌(苏州)股份有限公司 一种改善微塑料污染引起的炎症反应的副干酪乳杆菌及其应用
CN116590184B (zh) * 2023-04-28 2024-03-08 山东康祐生物科技有限公司 一种提升免疫力的后生元制品及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049303A1 (en) * 1996-06-21 1997-12-31 Quest International B.V. Fermentation of fruit products
US20090136468A1 (en) * 2004-10-29 2009-05-28 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
JP2009102270A (ja) * 2007-10-24 2009-05-14 Tsujido Kagaku Kk 脂肪代謝抑制剤
EP2065048A1 (en) * 2007-11-30 2009-06-03 Institut Pasteur Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
WO2015172191A1 (en) * 2014-05-12 2015-11-19 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
CN104212740A (zh) * 2014-08-14 2014-12-17 任发政 干酪乳杆菌及其应用以及功能食品组合物

Also Published As

Publication number Publication date
CN109312297A (zh) 2019-02-05
WO2017097984A1 (en) 2017-06-15
EP3387156A1 (en) 2018-10-17
ES2807915T3 (es) 2021-02-24
US11490643B2 (en) 2022-11-08
US20210282444A1 (en) 2021-09-16
EP3387156B1 (en) 2020-04-29
US20180360092A1 (en) 2018-12-20
CN109312297B (zh) 2022-09-23
PL3387156T3 (pl) 2020-11-16

Similar Documents

Publication Publication Date Title
DK3387156T3 (da) Lactobacillus casei til behandling af fedme og associerede metabolske sygdomme
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3858977T5 (da) Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf
DK3442580T3 (da) Fremgangsmåder til behandling af kolestatiske og fibrotiske sygdomme
DK3386523T3 (da) Bifidobacterium longum til behandling af fedme og associerede metabolske sygdomme
DK3445388T3 (da) Materialer og fremgangsmåder til behandling af hæmoglobinopatier
DK3259597T3 (da) Pvrig-polypeptider og fremgangsmåder til behandling
DK2990084T3 (da) Gangtræningsapparat og styringsfremgangsmåde dertil
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
PL3265043T3 (pl) Urządzenie pomagające w przenoszeniu i ćwiczeniach pacjenta
DK3129018T3 (da) Behandling af NAFLD og NASH
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3204497T3 (da) Terapeutisk hæmning af lactatdehydrogenase og midler dertil
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3277295T3 (da) Sammensætning til behandling af en patogen, metabolisk tarmmikrobiotatilstand og afledte sygdomme
DK3233066T3 (da) Orlistat- og acarbosepræparat med modificeret frigivelse til behand-ling af obesitas og relaterede metaboliske lidelser
DK3157522T3 (da) Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
DK3326635T3 (da) Behandling og forebyggelse af forkølelse ved hjælp af povidon-iod
DK3615502T3 (da) Terapeutiske forbindelser og fremgangsmåder
DK3122743T3 (da) Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme
DK3229827T3 (da) Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme
DK3157532T3 (da) Fremgangsmåder til behandling og forebyggelse af sygdomme med vaskulær instabilitet
DK3445362T3 (da) Sammensætning og fremgangsmåde til behandling af stofskiftesygdomme
IL265269B (en) New compounds and their medicinal uses